119 related articles for article (PubMed ID: 38179652)
1. Computational Studies Show How the H463R Mutation Turns hKv1.5 into an Inactivation State.
Rahman RA; Zaman B; Khan MR; Islam MS; Rashid MH
J Phys Chem B; 2024 Jan; 128(2):429-439. PubMed ID: 38179652
[TBL] [Abstract][Full Text] [Related]
2. Identification of Verapamil Binding Sites Within Human Kv1.5 Channel Using Mutagenesis and Docking Simulation.
Ding WG; Tano A; Mi X; Kojima A; Seto T; Matsuura H
Cell Physiol Biochem; 2019; 52(2):302-314. PubMed ID: 30816676
[TBL] [Abstract][Full Text] [Related]
3. Interactions of Propofol With Human Voltage-gated Kv1.5 Channel Determined by Docking Simulation and Mutagenesis Analyses.
Kojima A; Fukushima Y; Ito Y; Ding WG; Ueda R; Seto T; Kitagawa H; Matsuura H
J Cardiovasc Pharmacol; 2018 Jan; 71(1):10-18. PubMed ID: 29283926
[TBL] [Abstract][Full Text] [Related]
4. Interaction of propofol with voltage-gated human Kv1.5 channel through specific amino acids within the pore region.
Kojima A; Ito Y; Ding WG; Kitagawa H; Matsuura H
Eur J Pharmacol; 2015 Oct; 764():622-632. PubMed ID: 26256861
[TBL] [Abstract][Full Text] [Related]
5. Kinetic Aspects of Verapamil Binding (On-Rate) on Wild-Type and Six hKv1.3 Mutant Channels.
Diesch AK; Grissmer S
Cell Physiol Biochem; 2017; 44(1):172-184. PubMed ID: 29131061
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the σ-Pore in Mutant hKv1.3 Potassium Channels.
Tyutyaev P; Grissmer S
Cell Physiol Biochem; 2018; 46(3):1112-1121. PubMed ID: 29669325
[TBL] [Abstract][Full Text] [Related]
7. Regulation of a mammalian Shaker-related potassium channel, hKv1.5, by extracellular potassium and pH.
Jäger H; Grissmer S
FEBS Lett; 2001 Jan; 488(1-2):45-50. PubMed ID: 11163793
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of action of antiarrhythmic agent bertosamil on hKv1.5 channels and outward potassium current in human atrial myocytes.
Godreau D; Vranckx R; Hatem SN
J Pharmacol Exp Ther; 2002 Feb; 300(2):612-20. PubMed ID: 11805224
[TBL] [Abstract][Full Text] [Related]
9. Acacetin causes a frequency- and use-dependent blockade of hKv1.5 channels by binding to the S6 domain.
Wu HJ; Wu W; Sun HY; Qin GW; Wang HB; Wang P; Yalamanchili HK; Wang J; Tse HF; Lau CP; Vanhoutte PM; Li GR
J Mol Cell Cardiol; 2011 Dec; 51(6):966-73. PubMed ID: 21906601
[TBL] [Abstract][Full Text] [Related]
10. Structure, molecular modeling, and function of the novel potassium channel blocker urotoxin isolated from the venom of the Australian scorpion Urodacus yaschenkoi.
Luna-Ramírez K; Bartok A; Restano-Cassulini R; Quintero-Hernández V; Coronas FI; Christensen J; Wright CE; Panyi G; Possani LD
Mol Pharmacol; 2014 Jul; 86(1):28-41. PubMed ID: 24723491
[TBL] [Abstract][Full Text] [Related]
11. Effects of oxypeucedanin on hKv1.5 and action potential duration.
Eun JS; Park JA; Choi BH; Cho SK; Kim DK; Kwak YG
Biol Pharm Bull; 2005 Apr; 28(4):657-60. PubMed ID: 15802805
[TBL] [Abstract][Full Text] [Related]
12. The effects of ginsenoside Rg(3) on human Kv1.4 channel currents without the N-terminal rapid inactivation domain.
Lee JH; Choi SH; Lee BH; Shin TJ; Pyo MK; Hwang SH; Kim BR; Lee SM; Bae DH; Rhim H; Nah SY
Biol Pharm Bull; 2009 Apr; 32(4):614-8. PubMed ID: 19336893
[TBL] [Abstract][Full Text] [Related]
13. Observation of σ-pore currents in mutant hKv1.2_V370C potassium channels.
Tyutyaev P; Grissmer S
PLoS One; 2017; 12(4):e0176078. PubMed ID: 28426823
[TBL] [Abstract][Full Text] [Related]
14. Long-term 4-AP treatment facilitates functional expression of human Kv1.5 channel.
Xie Y; Ding WG; Liu Y; Yu M; Sun X; Matsuura H
Eur J Pharmacol; 2019 Feb; 844():195-203. PubMed ID: 30552904
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of psoralen derivatives and their blocking effect of hKv1.5 channel.
Eun JS; Kim KS; Kim HN; Park SA; Ma TZ; Lee KA; Kim DK; Kim HK; Kim IS; Jung YH; Zee OP; Yoo DJ; Kwak YG
Arch Pharm Res; 2007 Feb; 30(2):155-60. PubMed ID: 17366735
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the KCNA1 gene associated with episodic ataxia type-1 syndrome impair heteromeric voltage-gated K(+) channel function.
D'Adamo MC; Imbrici P; Sponcichetti F; Pessia M
FASEB J; 1999 Aug; 13(11):1335-45. PubMed ID: 10428758
[TBL] [Abstract][Full Text] [Related]
17. Open channel block of Kv1.5 channels by HMQ1611.
Dong C; Li J; Ding W; Ueda R; Xie X; Wu J; Matsuura H; Horie M
Front Pharmacol; 2022; 13():965086. PubMed ID: 36188606
[TBL] [Abstract][Full Text] [Related]
18. Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5.
Perchenet L; Hilfiger L; Mizrahi J; Clément-Chomienne O
J Pharmacol Exp Ther; 2001 Sep; 298(3):1108-19. PubMed ID: 11504808
[TBL] [Abstract][Full Text] [Related]
19. Effects of irbesartan on cloned potassium channels involved in human cardiac repolarization.
Moreno I; Caballero R; González T; Arias C; Valenzuela C; Iriepa I; Gálvez E; Tamargo J; Delpón E
J Pharmacol Exp Ther; 2003 Feb; 304(2):862-73. PubMed ID: 12538844
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis involved in the blocking effect of antidepressant metergoline on C-type inactivation of Kv1.4 channel.
Bai HW; Eom S; Yeom HD; Nguyen KVA; Lee J; Sohn SO; Lee JH
Neuropharmacology; 2019 Mar; 146():65-73. PubMed ID: 30465811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
